Translational Development Acquisition TDAC
NASDAQ TDAC
$10.84 -0.01 (-0.09%)
At close: Aug 20, 2026 · 4:00 PM EDT

Translational Development Acquisition (TDAC) Enterprise Value (2023 - 2025)

Translational Development Acquisition's (TDAC) quarterly Enterprise Value came in at -$29787.0 in Q4 2025, up 36.83% on a QoQ basis from -$47150.0 in Q3 2025.

Translational Development Acquisition (TDAC) Enterprise Value (2023 - 2025) Analysis & Trends

Translational Development Acquisition (TDAC) has 2 years of Enterprise Value data on file, last reported at -$29787.0 in Q4 2025.

  • Quarterly Enterprise Value changed N/A year-over-year to -$29787.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$29787.0 (changed N/A YoY) and the FY2025 annual result came in at -$29787.0, changed N/A from the prior year.
  • Enterprise Value advanced to -$29787.0 in Q4 2025, from -$47150.0 in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$2021.0 in Q4 2023 to a low of -$47150.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Launch Two Acquisition 557.86 Mn 557.86 Mn - -250,000.00
2 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - -174,974.00
3 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - -25,000.00
4 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -10,586.00
5 Aldel Financial 397.49 Mn 397.49 Mn - -283,112.00
6 Gores Holdings X 381.05 Mn 380.85 Mn - -194,541.00
7 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - -250,000.00
8 Blue Water Acquisition Corp. III 342.12 Mn 342.08 Mn - -32,560.00
9 Berto Acquisition 313.96 Mn 313.81 Mn - -147,000.00
10 Translational Development Acquisition 182.66 Mn 182.57 Mn - -85,877.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -29,787.00
Sep 30, 2025 -47,150.00
Jun 30, 2025 -35,255.00
Dec 31, 2023 -2,021.00